Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic
- 1 November 2020
- journal article
- research article
- Published by Elsevier BV in Respiratory Investigation
- Vol. 58 (6), 437-439
- https://doi.org/10.1016/j.resinv.2020.08.006
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Coronavirus Disease 2019–COVID-19Clinical Microbiology Reviews, 2020
- Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 PandemicACR Open Rheumatology, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals Of The Rheumatic Diseases, 2020
- COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILDAnnals Of The Rheumatic Diseases, 2020
- Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater ParisEuropean Respiratory Journal, 2017
- The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised HostsClinical Infectious Diseases, 2013
- The epidemiology of interstitial lung diseases.American Journal of Respiratory and Critical Care Medicine, 1994